PL2181990T3 - Pochodne piperydyny - Google Patents

Pochodne piperydyny

Info

Publication number
PL2181990T3
PL2181990T3 PL08828181T PL08828181T PL2181990T3 PL 2181990 T3 PL2181990 T3 PL 2181990T3 PL 08828181 T PL08828181 T PL 08828181T PL 08828181 T PL08828181 T PL 08828181T PL 2181990 T3 PL2181990 T3 PL 2181990T3
Authority
PL
Poland
Prior art keywords
piperidine derivative
piperidine
derivative
Prior art date
Application number
PL08828181T
Other languages
English (en)
Inventor
Akio Kakefuda
Kazushi Watanabe
Akio Kamikawa
Kentaro Enjo
Takashi Furutani
Minoru Yasuda
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PL2181990T3 publication Critical patent/PL2181990T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4465Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL08828181T 2007-08-31 2008-08-28 Pochodne piperydyny PL2181990T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007225378 2007-08-31
EP08828181A EP2181990B1 (en) 2007-08-31 2008-08-28 Piperidine derivative
PCT/JP2008/065429 WO2009028618A1 (ja) 2007-08-31 2008-08-28 ピペリジン誘導体

Publications (1)

Publication Number Publication Date
PL2181990T3 true PL2181990T3 (pl) 2013-01-31

Family

ID=40387332

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08828181T PL2181990T3 (pl) 2007-08-31 2008-08-28 Pochodne piperydyny

Country Status (20)

Country Link
US (1) US8513422B2 (pl)
EP (1) EP2181990B1 (pl)
JP (1) JP5327051B2 (pl)
KR (1) KR20100050444A (pl)
CN (1) CN101821253B (pl)
AU (1) AU2008292420A1 (pl)
BR (1) BRPI0815787A2 (pl)
CA (1) CA2696799A1 (pl)
CY (1) CY1113417T1 (pl)
DK (1) DK2181990T3 (pl)
ES (1) ES2392120T3 (pl)
HR (1) HRP20120837T1 (pl)
MX (1) MX2010002268A (pl)
PL (1) PL2181990T3 (pl)
PT (1) PT2181990E (pl)
RU (1) RU2470020C2 (pl)
SI (1) SI2181990T1 (pl)
TW (1) TW200924765A (pl)
WO (1) WO2009028618A1 (pl)
ZA (1) ZA201000917B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5609150B2 (ja) * 2009-02-27 2014-10-22 アステラス製薬株式会社 ピペリジン誘導体
JP2012102017A (ja) * 2009-03-03 2012-05-31 Astellas Pharma Inc インドール化合物
JP2012102018A (ja) * 2009-03-03 2012-05-31 Astellas Pharma Inc アミド化合物
JP5851998B2 (ja) * 2009-10-27 2016-02-03 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 殺虫剤および殺ダニ剤としてのハロアルキル置換アミド

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116732D0 (en) 1991-08-02 1991-09-18 Fujisawa Pharmaceutical Co Indole derivatives
AU680870B2 (en) 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
JP2002515891A (ja) 1997-12-19 2002-05-28 スミスクライン・ビーチャム・コーポレイション 新規なピペリジン含有化合物
JP2002506077A (ja) 1998-03-11 2002-02-26 アンドルシェルシュ・インコーポレイテッド タイプ5およびタイプ317β−ヒドロキシステロイドデヒドロゲナーゼのインヒビターおよびその使用法
AU5144999A (en) * 1998-08-07 2000-02-28 Endorecherche Inc. Inhibition of type 3 3alpha-hydroxysteroid dehydrogenase
MXPA03003174A (es) * 2000-10-10 2003-07-14 Smithkline Beecham Corp Indoles substituidos, composiciones farmaceuticas que contienen dichos indoles y su uso como agentes de enlace ppar-y..
EP1373204B1 (en) 2001-03-09 2016-10-26 Janssen Pharmaceuticals, Inc. Heterocyclic compounds
JP4623962B2 (ja) 2001-10-22 2011-02-02 ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク タンパク質キナーゼおよびホスファターゼ阻害剤、それらを設計する方法、ならびにそれらを使用する方法
WO2003049736A1 (en) 2001-12-11 2003-06-19 Sepracor, Inc. 4-substituted piperidines, and methods of use thereof
MXPA05007572A (es) 2003-01-17 2005-11-17 Threshold Pharmaceuticals Inc Tratamiento de hiperplasia prostatica benigna.
EP1615698B1 (en) 2003-04-11 2010-09-29 High Point Pharmaceuticals, LLC New amide derivatives and pharmaceutical use thereof
AP2006003549A0 (en) 2003-08-21 2006-04-30 Osi Pharm Inc N-substituted benzimidazolyl C-kit inhibitors.
WO2005040112A1 (en) * 2003-10-14 2005-05-06 Oxagen Limited Compounds with pgd2 antagonist activity
JP2005162657A (ja) 2003-12-02 2005-06-23 Takeda Chem Ind Ltd カンナビノイド受容体調節剤
JPWO2005082905A1 (ja) * 2004-02-26 2007-08-02 協和醗酵工業株式会社 二環性複素環化合物
CN1980934B (zh) 2004-05-03 2011-10-26 詹森药业有限公司 作为选择性雄激素受体调节剂(sarms)的新的吲哚衍生物
CN102091068B (zh) 2004-05-03 2012-09-19 詹森药业有限公司 作为选择性雄激素受体调节剂(sarms)的吲哚、苯并呋喃和苯并噻吩衍生物
BRPI0512335A (pt) * 2004-06-21 2008-03-04 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades e sua utilização
US20080234349A1 (en) * 2005-09-07 2008-09-25 Jack Lin PPAR active compounds
EP2298770A1 (en) 2005-11-03 2011-03-23 ChemBridge Corporation Heterocyclic compounds as TrkA modulators
US7855225B2 (en) 2006-03-02 2010-12-21 Astellas Pharma Inc. 17βHSD type 5 inhibitor

Also Published As

Publication number Publication date
PT2181990E (pt) 2012-10-16
JP5327051B2 (ja) 2013-10-30
JPWO2009028618A1 (ja) 2010-12-02
KR20100050444A (ko) 2010-05-13
DK2181990T3 (da) 2012-09-10
HRP20120837T1 (hr) 2012-11-30
US20100256189A1 (en) 2010-10-07
TW200924765A (en) 2009-06-16
EP2181990B1 (en) 2012-08-08
MX2010002268A (es) 2010-03-25
SI2181990T1 (sl) 2012-10-30
AU2008292420A1 (en) 2009-03-05
CA2696799A1 (en) 2009-03-05
ES2392120T3 (es) 2012-12-04
RU2010112412A (ru) 2011-10-10
EP2181990A4 (en) 2011-09-07
EP2181990A1 (en) 2010-05-05
US8513422B2 (en) 2013-08-20
BRPI0815787A2 (pt) 2015-02-24
WO2009028618A1 (ja) 2009-03-05
ZA201000917B (en) 2011-04-28
RU2470020C2 (ru) 2012-12-20
CN101821253A (zh) 2010-09-01
CN101821253B (zh) 2013-07-17
CY1113417T1 (el) 2016-06-22

Similar Documents

Publication Publication Date Title
EP2120573A4 (en) DERIVATIVES OF PIPERIDINE
EP2226315A4 (en) 2-AMINOQUINAZOLINE DERIVATIVE
ZA200908298B (en) Bicycloaniline derivative
EP2213673A4 (en) PYRIDONE-SUBSTITUTED DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE
PL2017278T3 (pl) Pochodne dihydropirazolopirymidynonu
EP2009005A4 (en) AZOLECARBOXAMIDE DERIVATIVE
EP2098517A4 (en) NEW PHENYLISOXAZOLE-3-OLDERIVATE
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
HK1158189A1 (en) Morpholinopurine derivative
IL196734A0 (en) Piperidine derivatives
EP2269993A4 (en) 2-aminoquinazoline DERIVATIVE
IL206875A0 (en) Bicycloamine derivative
HK1144196A1 (en) 4-pyrimidinesulfamide derivative 4-
IL208623A0 (en) Cyclopentylacrylamide derivative
EP2163554A4 (en) PYRIMIDODIAZEPINONE DERIVATIVE
EP2157084A4 (en) 5-phenyl-3-pyridazinone derivative
IL207315A0 (en) Piperidine derivative
EP2258697A4 (en) HYDROXYCHINOXALINCARBOXAMIDDERIVAT
EP2248811A4 (en) 2-OXOCHROMENE DERIVATIVE
ZA201000917B (en) Piperidine derivative
IL212683A0 (en) Biphenylacetamide derivative
EP2228362A4 (en) 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE
EP2184272A4 (en) PIPERAZINE DERIVATIVE
EP2328892A4 (en) Oxo-tetrahydrofuran-2-YL-benzimidazole derivative